CCL2 and Parkinson disease: Treatment with EV-SR3677 reduced MCP-1 expression in the brains (Figure 2A), kidneys (Figure 2C), and spleens (Figure 2D) by 7-, 9-, and 12-fold, respectively, compared to the results for similar organs from PD mice treated with saline.